CVKD Q1 2026 Earnings Narrowing Losses and Steady Progress in Clinical Pipeline TC Q3 2021 Earnings Significant EPS Miss as Losses Deepen NEN Q4 2024 Earnings Strong PerUnit Earnings Highlight Steady Real Estate Performance AURA Q1 2026 Earnings EPS Misses Estimates Stock Rises 24 on PreClinical Progress xAI Faces Employee Payment Delays Over 420 Tax Return Incentive